nmi health inc (NANM) Key Developments
NMI Health Inc. Announces Executive and Directorate Changes
Apr 16 14
NMI Health Inc. announced that Michael Marx has returned as CFO and director and that Dr. Marc Kahn has returned as a director.
NMI Health Inc. Enters into Settlement Agreement with Applied Nanoscience Inc
Apr 16 14
NMI Health Inc. announced that it had entered into a settlement agreement with Applied Nanoscience Inc. to end over three years of litigation. NMI had been facing a $601,041 judgment to pay Applied Nanoscience in principal, interest and attorney fees awarded in August 2013.
NMI Health Inc. Announces Resignation of Directors
Aug 20 13
NMI Health Inc. announced that it has accepted the resignations of Michael Marx and Marc Kahn as officers and directors of the company, and the resignation of Vicky Aksland as a director of the company, all effective as of August 19, 2013.
District Court of Clark County Announces Judgment in Favor of Applied Nanoscience, Inc. Against NMI Health Inc
Aug 9 13
On August 5, 2013, a judgment was entered against NMI Health Inc. in favor of plaintiff Applied Nanoscience Inc., in the District Court of Clark County in Nevada (Case No. A-10-631192-C). The judgment calls for the company to pay the plaintiff $547,658.64 in principal and interest on certain outstanding promissory notes plus attorneys fees. At this time, the company is considering the material adverse impact of the judgment on the company and its ability to continue operations.
Nmi Health Inc. Accepts Resignation of David Willoughby as an Officer and Director, Effective August 9, 2013
Aug 9 13
NMI Health Inc. has accepted the resignation of David Willoughby as an officer and director, such resignation to be effective August 9, 2013. Mr. Willoughby resigned for personal reasons not as the result of any disagreement with the company on any matter relating to the company's operations, policies or practices.